
A recent study conducted by researchers from China and published in the journal Gut has explored the risk of hepatocellular carcinoma in patients cured of hepatitis C. The findings reveal that advanced steatosis grade is independently associated with an increased risk of liver cancer following the cure. <b>Hepatocellular carcinoma</b> risks were assessed across 700 patients who received regular surveillance after hepatitis C treatment. The study concluded that advanced steatosis grades and specific cardiometabolic risk factors like glycemic irregularities significantly correlate with higher cancer risk.
This page is a shareable card. Download our app to get the full swipe experience!